Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 1

1(33.3%)

Phase 4

1(33.3%)

3Total

N/A(1)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04648033Phase 1Completed

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

Role: collaborator

NCT06714630Recruiting

The PROSECCA Study, Answering New Questions in Prostate Cancer

Role: collaborator

NCT06026579Completed

Clinical Characteristics and Subgroups in Greater Trochanteric Pain Syndrome

Role: collaborator

NCT04622995Completed

Benzodiazepines in Opiate Replacement Therapy

Role: collaborator

NCT05516420Completed

Predicting Abdominal Reoperation

Role: collaborator

NCT03659955Not ApplicableCompleted

Autologous Blood Treatment for Ocular Surface Disease

Role: collaborator

NCT01674933Phase 4Completed

Fluoride Varnish For Childsmile Nursery School Attenders

Role: collaborator

All 7 trials loaded